This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
We are very excited to launch our new website! Please take a few moments to click around and explore...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...